Risk stratification for lung cancer surgery: Impact of induction therapy and extended resection

Chest

Volumn 128, Issue 5, 2005, Pages 3519-3525

  Matsubara, Yoko ^a   Takeda, Shin Ichi ^a   Mashimo, Takashi ^b  

^a TONEYAMA NATIONAL HOSPITAL   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Extended surgery; Induction therapy; Lung cancer; Pulmonary resection; Risk stratification

Indexed keywords

CARBOPLATIN; CISPLATIN; DOCETAXEL; HEMOGLOBIN; MITOMYCIN C; NAVELBINE; VINDESINE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER MORTALITY; CANCER STAGING; CANCER SURGERY; FEMALE; HEMOGLOBIN DETERMINATION; HUMAN; HUMAN TISSUE; LOBECTOMY; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OPERATION DURATION; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PERIOD; PREDICTION; PREOPERATIVE EVALUATION; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE; SURGICAL MORTALITY; SURGICAL RISK; TEACHING HOSPITAL;

EID: 28144447453     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.128.5.3519     Document Type: Article

References (28)

1. Wada H, Nakamura T, Nakamoto K, et al. Thirty day operative mortality for thoracotomy in lung cancer. J Thorac Cardiovasc Surg 1998; 115:70-73
2. Suzuki K, Nagai K, Yoshida J, et al. Prognostic factors in clinical stage I non-small cell lung cancer. Ann Thorac Surg 1999; 67:927-932
3. Sone S, Takashima S, Asakura K, et al. Mass screening for lung cancer with mobile spiral computed tomography scanner. Lancet 1998; 351:1242-1245
4. Sugarbaker DJ, Herndon J, Kohman LJ, et al. Results of cancer and leukemia group B protocol 8935: a multiinstitutional phase II trimodality trial for stage IIIA (N2) non-small cell lung cancer; Cancer and Leukemia Group B Thoracic Surgery Group. J Thorac Cardiovasc Surg 1995; 109:473-485
5. Albain KS, Rusch VW, Crowley JJ, et al. Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stage IIIA (N2) and IIIB. J Clin Oncol 1995; 13:1880-1892
6. Fowler WC, Langer CJ, Curran WJ Jr, et al. Postoperative complications after combined neoadjuvant treatment of lung cancer. Ann Thorac Surg 1993; 55:986-989
7. Roberts JR, Eustis C, Devore R, et al. Induction chemotherapy increases perioperative complications in patients undergoing resection for non-small cell lung cancer. Ann Thorac Surg 2001; 72:885-888
8. Nakahara K, Monden Y, Ohno K, et al. A method for predicting postoperative lung function and its relation to postoperative complications in patients with lung cancer. Ann Thorac Surg 1985; 39:260-265
9. Nakahara K, Ohno K, Hashimoto J, et al. Prediction of postoperative respiratory failure on patients with lung cancer. Ann Thorac Surg 1988; 46:549-552
10. Ohta M, Sawabata M, Maeda H, et al. Efficacy and safety of tracheobronchoplasty after induction therapy for locally advanced lung cancer. J Thorac Cardiovasc Surg 2003; 125:96-100
11. Nagasaki F, Flehinger BJ, Martini N. Complications of surgery in the treatment of carcinoma of the lung. Chest 1982; 82:25-29
12. Ginsberg RJ, Hill LD, Eagan RT, et al. Modern thirty-day operative mortality for surgical resections in lung cancer. J Thorac Cardiovasc Surg 1983; 86:654-658
13. Keagy BA, Lores ME, Starek PJK, et al. Elective pulmonary lobectomy: factors associated with morbidity and operative mortality. Ann Thorac Surg 1985; 40:349-352
14. Deslauriers J, Ginsberg RJ, Plantadosi S, et al. Prospective assessment of 30-day operative morbidity for surgical resections in lung cancer. Chest 1994; 106(suppl):329-330S
15. Duque JL, Ramos G, Castrodeza J, et al. Early complications in surgical treatment of lung cancer: a prospective, multicenter study. Ann Thorac Surg 1997; 63:944-950
16. Bernard A, Ferrand L, Hagry O, et al. Identification of prognostic factors determining risk groups for lung resection. Ann Thorac Surg 2000; 70:1161-1167
17. Watanabe S, Asamura H, Suzuki K, et al. Recent results of postoperative mortality for surgical resections in lung cancer. Ann Thorac Surg 2004; 78:999-1003
18. Martin J, Ginsberg RJ, Abolhoda A, et al. Morbidity and mortality after neoadjuvant therapy for lung cancers. Ann Thorac Surg 2001; 72:1149-1154
19. Siegenthaler MF, Merriman KW, Roth JA, et al. Preoperative chemotherapy tor lung cancer does not increase surgical morbidity. Ann Thorac Surg 2001; 71:1105-1112
20. Stamatis G, Djuric D, Eberhardt W, et al. Postoperative morbidity and mortality after induction chemoradiotherapy for locally advanced lung cancer: an analysis of 350 operated patients. Eur J Cardiothorac Surg 2002; 22:292-297
21. Epstein SK, Faring JL, Celli BR, et al. Predicting complications after pulmonary resection: preoperative exercise testing vs. multifactorial cardiopulmonary risk index. Chest 1993; 104:694-700
22. Tedder M, Anstadt MP, Tedder SD, et al. Current morbidity, mortality and survival after bronchoplastic procedure. Ann Thorac Surg 1992; 54:387-391
23. Van Raemdonck DE, Schneider A, Ginsberg RJ, et al. Surgical treatment for higher stage non-small cell lung cancer. Ann Thorac Surg 1992; 54:999-1013
24. Busch E, Verazin G, Antkowiak JG, et al. Pulmonary complications in patients undergoing thoracotomy for lung carcinomas. Chest 1994; 104:760-766
25. Izbicki JR, Knoefel WT, Passlick B, et al. Risk analysis and long-term survival in patients undergoing extended resection of locally advanced lung cancer. J Thorac Cardiovasc Surg 1995; 110:386-395
26. Takeda S, Miyoshi S, Maeda H, et al. Ventilatory muscle recruitment and work of breathing in patients with respiratory failure after thoracic surgery. Eur J Cardiothorac Surg 1999; 15:449-455
27. Takeda S, Estrera AS, Hsia CCW. In vivo estimation of septal lung tissue volume and correlation with diffusing capacity in lung volume reduction surgery. J Thorac Cardiovasc Surg 2000; 119:191-192
28. Kutlu CA, Williams EA, Goldstraw P, et al. Acute lung injury and acute respiratory syndrome after pulmonary resection. Ann Thorac Surg 2000; 69:376-380